Natco Pharma Limited Sorafenib Export Data — India (DGFT 2022–2026)

Name: Natco Pharma Limited Sorafenib Export Records India — #2 Exporter, 17 Shipments, $850.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Sorafenib

India Pharmaceutical Trade Intelligence

$16.6M203 Suppliers98 CountriesHS 30049049

ExportsIndia → UNITED STATES75.0%India → SAUDI ARABIA6.5%

ImportsGERMANY → India$172.7K ROMANIA → India$33.3K

#1 Buyer: TORRENT PHARMA

Natco Pharma Limited — Sorafenib Exporter #2 | $850.0K Trade Value | TransData Nexus | TransData Nexus

Natco Pharma Limited — Sorafenib Exporter Profile

Indian Pharmaceutical Exporter · #2 for Sorafenib · $850.0K export value · DGFT Verified

Natco Pharma Limited is the #2 Indian exporter of Sorafenib with $850.0K in export value and 17 verified shipments. Natco Pharma Limited holds a 5.1% market share in Sorafenib exports across 4 countries. The company exports 17 pharmaceutical products worth $36.0M across 6 therapeutic categories.

Natco Pharma Limited — Sorafenib Export Profile: Buyers & Destinations

Natco Pharma Limited Sorafenib export treemap — buyers and destination countries | TransData Nexus

Where Does Natco Pharma Limited Export Sorafenib?

Country	Value	Shipments	Share
THAILAND	$150.0K	3	55.6%
SAUDI ARABIA	$50.0K	1	18.5%
FRANCE	$50.0K	1	18.5%
NEPAL	$19.9K	12	7.4%

Who Are the Top Buyers of Sorafenib from Natco Pharma Limited?

Buyer	Country	Value	Orders
ATLANTA MEDICARE CO LTD	THAILAND	$100.0K	2
ATLANTA MEDICARE CO. LTD	THAILAND	$50.0K	1
BOSTON ONCOLOGY ARABIA	SAUDI ARABIA	$50.0K	1
SOPHAL SPA	FRANCE	$50.0K	1
EVEREST BANK LTD	NEPAL	$11.7K	7
EVEREST BANK LIMITED	NEPAL	$5.8K	3
EVEREST BANK LTD.	NEPAL	$2.3K	2

Natco Pharma Limited supplies Sorafenib to 7 buyers globally. The largest buyer is ATLANTA MEDICARE CO LTD (THAILAND), followed by ATLANTA MEDICARE CO. LTD (THAILAND) and BOSTON ONCOLOGY ARABIA (SAUDI ARABIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Sorafenib Formulations Does Natco Pharma Limited Export?

Product Description / Formulation	Value	Shipments
SORAFENAT 200MG TABLETS 60'S(SORAFENIB T	$50.0K	1
SORAFENAT 200MG TABLETS 60'S SORAFENIBTOSYLATE1706X60'SAPPENDIX 4R,RODTEPENTRY NO:10112OTHERREFSCI NO:123164	$50.0K	1
SORAFENIB 200MG TABLETS (APPENDIX 4R RODTEP ENTRY NO: 10112 (OTHER REF CI NO:124049)	$50.0K	1
SORAFENIB 200MG TABLETS (SORAPHAL 200MG) (1280X100'S) (APPENDIX 4R RODTEP ENTRY NO.10112) (OUR REF INV NO.124268)	$50.0K	1
SORAFENAT 200MG TABLETS 60 S SORAFENIB TOSYLATE 1550X60 S APPENDIX 4R RODTEPENTRY NO 10112 OUR REF S CI NO125043	$50.0K	1
SORAFENAT 120'S PER BOTTLE (SORAFENIB TABLETS 200MG)(75X120'S)(APPENDIX4R,RODTEP ENTRYNO:10112)	$5.0K	1
SORAFENAT 200MG TAB 120'S(SORAFENIB TABLETS)(50X120'S)(APPENDIX4R,RODTEPENTRY NO:10112)(OTHERREF(S)CINO:CWH-2023-017)NOS	$3.6K	1
SORAFENAT 120 S PER BOTTLE SORAFENIB TABLETS 200MG 50X120 S APPENDIX4R RODTEPENTRYNO 10112	$3.4K	1
SORAFENAT 200MG TABLETS 120'S (SORAFENIB200MG)(25X120'S)(APPENDIX4RRODTEPENTRYNO:10112)	$1.8K	1
SORAFENAT 200MG TABLETS 120'S (SORAFENIB200MG)(20X120'S)(APPENDIX4R,RODTEP ENTRYNO:10112)	$1.4K	1

Natco Pharma Limited exports 17 distinct Sorafenib formulations including tablets, capsules, syrups, and combination drugs. The top formulation is SORAFENAT 200MG TABLETS 60'S(SORAFENIB T with 1 shipments worth $50.0K.

How Does Natco Pharma Limited Compare to Nearest Sorafenib Exporters?

Exporters ranked immediately above and below #2 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	NATCO PHARMA LIMITED ★	$850.0K	17	4	$50.0K
1	TORRENT PHARMACEUTICALS LTD	$600.0K	12	2	$50.0K
3	MEDYRA PHARMACEUTICAL	$162.4K	15	4	$10.8K

Natco Pharma Limited ranks #2 among 203 Indian Sorafenib exporters. Average shipment value of $50.0K compared to the market average of $9.3K. The closest competitors by value are TORRENT PHARMACEUTICALS LTD and MEDYRA PHARMACEUTICAL.

Which Indian Ports Ship Sorafenib Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	245	26.7%
SAHAR AIR	197	21.5%
DELHI AIR CARGO ACC (INDEL4)	89	9.7%
Bombay Air	69	7.5%
DELHI AIR	68	7.4%
AHEMDABAD AIR	37	4.0%
Bombay Air Cargo	27	2.9%
AHEMDABAD AIR ACC (INAMD4)	20	2.2%

Geopolitical & Trade Policy Impact on Natco Pharma Limited's Sorafenib Exports

Natco's export operations are currently navigating a complex geopolitical landscape. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. These challenges are particularly impactful for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in logistics and supply chain management. (pharmaceuticalcommerce.com)

In the United States, recent tariff implementations have introduced additional complexities for Indian pharmaceutical exporters. The U.S. administration's imposition of tariffs on imports from various countries, including India, has raised concerns about the competitiveness of Indian generics in the U.S. market. These tariffs could potentially erode profit margins and affect pricing strategies. (apnews.com)

Conversely, the European Union's stringent regulatory changes, such as the Falsified Medicines Directive, have heightened compliance requirements for exporters. While these regulations aim to ensure product authenticity and safety, they also necessitate significant investments in serialization and traceability systems. For companies like Natco, adhering to these standards is crucial for maintaining access to the lucrative EU market.

Natco Pharma Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing intensified scrutiny regarding quality and compliance. The U.S. Food and Drug Administration (FDA) has increased inspections of Indian manufacturing facilities, emphasizing adherence to Good Manufacturing Practices (GMP). Non-compliance can lead to warning letters, import alerts, or even bans, posing significant risks to exporters. (fact.net.in)

Natco's commitment to quality is evident in its proactive measures to meet international standards. The company's recent product approvals and successful market entries suggest a robust compliance framework. However, continuous vigilance and investment in quality systems are imperative to navigate the evolving regulatory landscape and to sustain export growth.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Sorafenib shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Natco Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 17 individual customs records matching Natco Pharma Limited exporting Sorafenib, covering 17 formulations to 4 countries via 7 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 98+ countries, 341+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Sorafenib

Sorafenib

Natco Pharma Limited — Sorafenib Exporter Profile

Natco Pharma Limited — Sorafenib Export Profile: Buyers & Destinations

Where Does Natco Pharma Limited Export Sorafenib?

Who Are the Top Buyers of Sorafenib from Natco Pharma Limited?

What Is India's Total Sorafenib Export Value and How Much Does Natco Pharma Limited Contribute?

What Is the Average Shipment Value for Natco Pharma Limited's Sorafenib Exports?

How Does Natco Pharma Limited Compare to Other Indian Sorafenib Exporters?

What Sorafenib Formulations Does Natco Pharma Limited Export?

How Does Natco Pharma Limited Compare to Nearest Sorafenib Exporters?

Which Indian Ports Ship Sorafenib Exports?

What Other Advanced Oncology Products Does Natco Pharma Limited Export?

Geopolitical & Trade Policy Impact on Natco Pharma Limited's Sorafenib Exports

Natco Pharma Limited — Regulatory Compliance & Quality Standards

About Natco Pharma Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Sorafenib Export Data from Natco Pharma Limited

Sorafenib Stats

Company Overview

Top Products by Natco Pharma Limited

Related Analysis

Need Detailed Export Data?

Data Source